In today’s session CVS Health Corp (CVS) registered an unusually high (4,641) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the October, 2016 call, expecting serious CVS increase. With 4,641 contracts traded and 36184 open interest for the Oct, 16 contract, it seems this is a quite bullish bet. The option with symbol: CVS161021C00089000 closed last at: $0.47 or 51.6% up. About 3.27M shares traded hands. CVS Health Corp (NYSE:CVS) has declined 12.10% since March 14, 2016 and is downtrending. It has underperformed by 17.71% the S&P500.
Analysts await CVS Health Corp (NYSE:CVS) to report earnings on November, 4. They expect $1.57 EPS, up 22.66% or $0.29 from last year’s $1.28 per share. CVS’s profit will be $1.69 billion for 13.85 P/E if the $1.57 EPS becomes a reality. After $1.32 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 18.94% EPS growth.
CVS Health Corp (NYSE:CVS) Ratings Coverage
Out of 15 analysts covering CVS Health (NYSE:CVS), 11 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 73% are positive. CVS Health has been the topic of 22 analyst reports since July 22, 2015 according to StockzIntelligence Inc. As per Friday, January 22, the company rating was initiated by Robert W. Baird. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Monday, June 20. The stock has “Neutral” rating given by Goldman Sachs on Thursday, December 17. Barclays Capital initiated CVS Health Corp (NYSE:CVS) rating on Friday, December 18. Barclays Capital has “Overweight” rating and $110 price target. The stock of CVS Health Corp (NYSE:CVS) earned “Buy” rating by Vetr on Monday, August 24. The rating was maintained by S&P Research with “Strong Buy” on Monday, November 2. Deutsche Bank maintained it with “Hold” rating and $117 target price in Wednesday, July 22 report. On Thursday, August 20 the stock rating was maintained by Deutsche Bank with “Hold”. The firm has “Overweight” rating by JP Morgan given on Monday, November 2. On Monday, November 2 the stock rating was maintained by Oppenheimer with “Outperform”.
According to Zacks Investment Research, “CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.”
Insitutional Activity: The institutional sentiment decreased to 1 in 2016 Q2. Its down 0.10, from 1.1 in 2016Q1. The ratio fall, as 67 funds sold all CVS Health Corp shares owned while 574 reduced positions. 97 funds bought stakes while 544 increased positions. They now own 833.68 million shares or 6.91% less from 895.55 million shares in 2016Q1.
Mark Sheptoff Fincl Planning Limited Co last reported 3.42% of its portfolio in the stock. The Ohio-based Trust Com Of Toledo Na Oh has invested 0.27% in CVS Health Corp (NYSE:CVS). Stratos Wealth Prtnrs Ltd has 39,661 shares for 0.28% of their US portfolio. Markston Intl Limited Liability, a New York-based fund reported 262,538 shares. Commercial Bank Of Stockton holds 1.02% of its portfolio in CVS Health Corp (NYSE:CVS) for 19,984 shares. Alliancebernstein Lp, a New York-based fund reported 10.78 million shares. Riverpoint Cap Management Lc, a Ohio-based fund reported 34,587 shares. Yhb Inv Advsrs accumulated 1.97% or 93,368 shares. New Mexico Educational Retirement Board has 125,187 shares for 0.54% of their US portfolio. Clarivest Asset has 1.45% invested in the company for 508,963 shares. Arcadia Investment Mgmt Mi has invested 0.05% of its portfolio in CVS Health Corp (NYSE:CVS). Balasa Dinverno & Foltz Ltd Llc holds 0.13% or 7,401 shares in its portfolio. Moreover, Hills Bank & Trust has 1.06% invested in CVS Health Corp (NYSE:CVS) for 30,015 shares. Patten Grp accumulated 0% or 5,243 shares. Cwm Limited Co has invested 0% of its portfolio in CVS Health Corp (NYSE:CVS).
Insider Transactions: Since May 5, 2016, the stock had 0 insider purchases, and 3 sales for $5.83 million net activity. $1.03 million worth of CVS Health Corp (NYSE:CVS) was sold by GOLD STEPHEN J on Thursday, May 5. Brennan Troyen A sold $789,285 worth of stock. MERLO LARRY J sold $4.02M worth of stock.
CVS Health Corporation, together with its subsidiaries , is a pharmacy company. The company has a market cap of $93.60 billion. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. It has a 20.02 P/E ratio. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
CVS Company Profile
CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries (CVS Health), is a pharmacy company. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.
More important recent CVS Health Corp (NYSE:CVS) news were published by: Schaeffersresearch.com which released: “Analyst Downgrades: CVS Health Corp, Dunkin Brands Group Inc, and Twitter Inc” on October 17, 2016, also Seekingalpha.com published article titled: “Why I Am Now Interested In CVS Health Corporation”, Benzinga.com published: “Jim Cramer On CVS Health Corp And Skechers USA Inc” on September 25, 2016. More interesting news about CVS Health Corp (NYSE:CVS) was released by: Law360.com and their article: “CVS Health Slapped With Infringement Suit Over Heart Logo” with publication date: September 21, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.